Document is current
Any future updates will be listed below
-
Authors
Fukushima, Takafumi
Numakura, Kazuyuki
Shinohara, Masanao
Kawashima, Yohei
Sekine, Yuya
Mori, Kanami
Kobayashi, Mizuki
Asanuma, Himawari
Ichiyama, Takaki
Sakurai, Hisashi
Ozaki, Kai
Fujita, Naoki
Okamoto, Teppei
Yamamoto, Hayato
Yoneyama, Takahiro
Sato, Satoshi
Habuchi, Tomonori
Ohyama, Chikara
Hatakeyama, Shingo https://orcid.org/0000-0002-0026-4079
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (20K09517)
- License Information
-
More Information
Article History
Received: 10 March 2025
Accepted: 30 June 2025
First Online: 18 July 2025
Declarations
:
: Shingo Hatakeyama received honoraria from Janssen Pharmaceutical K.K., Astellas Pharma Inc., AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., Bayer AG, Pfizer Inc., Bristol-Myers Squibb, Merck Biopharma Co., Ltd., Kaneka Corporation, and Nipro Corporation. The other authors have no conflicts of interest to declare.
: All authors approved for the publication.
: Shingo Hatakeyama received honoraria from Janssen Pharmaceutical K.K., Astellas Pharma Inc., AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., Bayer AG, Pfizer Inc., Bristol-Myers Squibb, Merck Biopharma Co., Ltd., Kaneka Corporation, and Nipro Corporation. The other authors have no conflicts of interest to declare.
: Written consent was not obtained in exchange for the public disclosure of study information (opt-out approach) by an Institutional Review Board by the ethics committee of the Hirosaki University School of Medicine (approval nos. 2019-099-2 and 2021-158-2, opt-out approach).
